Table 1.
Type of Study | Toxic Agent | Exposure Mode/Objetives | Results | Reference |
---|---|---|---|---|
Transversal study | GBH | Occupational exposure |
|
[45] |
Prospective cohort study | GBH | Not specified |
|
[46] |
Population-based case-control study | GBH | Occupational exposure |
|
[47] |
Cohort study | GBH | Occupational exposure |
|
[48] |
Cohort study | GBH | Occupational exposure |
|
[49] |
In vitro SH-SY5Y cell line |
GLY alone or mixed with other formulants: 5.33 to 3.200 μg/mL for 24 h | Investigate whether GBH toxicity is related to formulants |
|
[50] |
In vitro IMR90-c4 iPSCs line |
GLY, AMPA: 0.1 to 1000 μM for 24 or 48 h | Investigate the effect of GLY on the BBB in vitro and compare it with that of AMPA and glycine |
|
[51] |
In vitro SH-SY5Y cell line |
GLY, AMPA: 0.1 to 20 mM for 48 h | Investigate the effects of GLY and AMPA on oxidative stress, neurodevelopment, and cell death. |
|
[52] |
Abbreviations: GBH, glyphosate-based herbicide; ↑, increase; S100B, S100 calcium-binding protein B; GLY, glyphosate; iPSCs, induced pluripotent stem cells; AMPA, aminomethylphosphonic acid; BBB, blood–brain barrier; ↓, decrease; LDH, lactate dehydrogenase; MDA, malondialdehyde; NO, nitric oxide; ROS, reactive oxygen species; IL-6, interleukin-6; TNF-α, tumor necrosis factor alpha; CAMK2, Ca2+/calmodulin-dependent protein kinase 2.